Paul Toren

Uro-oncologist and researcher, Quebec City. Associate professor, Université Laval.

[Société Internationale d'Urologie Journal @SIU_Journal]

Check out this great article by Dr Kaleem Atchia et al. from the March #SIUJ issue!

📜 Article: https://t.co/H9yZQR6W1I
📘 Full issue: https://t.co/QDy7GzguqO

@DrTanWP @ptorenmd

[Paul Toren @ptorenmd]

Switching Cancers: A Systematic Review Assessing the Role of Androgen Suppressive Therapy in Bladder Cancer
https://t.co/1ohsO72IIw

[Paul Toren @ptorenmd]

NLR as a predictive biomarker for abiraterone in first line CRPC: Highly pertinent for patients, but needs validation studies!
https://t.co/9H3WOZj3nP

[Canadian Urological Association @CanUrolAssoc]

Professor Chapple presentation to the participants of the EAU CUA Exchange Dr. Joseph Chin, Melise Keays, Trustin Domes, Paul Toren. @ Barcelona, Spain

[Paul Toren @ptorenmd]

Great work! https://t.co/HoXOW78qXt

[Prostate Cancer Foundation @PCFnews]

PCF Young Investigator @AminaZoubeidi makes progress on the development of a novel new treatment for lethal, neuroendocrine #prostatecancer (NEPC).
https://t.co/zSGDwi7ku3

[Paul Toren @ptorenmd]

Good work Clovis! Bon travail! https://t.co/sYRHhSiJMp

[Endocrine-Related Cancer @EndoCancer]

New review on sex steroids in the tumor microenvironment and prostate cancer progression by Boibessot and Toren: https://t.co/VQ0KYiy74g